HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$3.74
+0.03 (+0.81%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +331.6% upside
Low Target $9.68
Average Target $16.14
High Target $20.98
Current Price $3.74
Current
$3.74
Target
$16.14
$9.68 $16.14 avg $20.98
Scenario Analysis
Bear Case
$9.68
158.8%
Low target
Base Case
$16.14
+331.6%
Avg target
Bull Case
$20.98
+461.0%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$17.18
-78.2% from high
52-Week Low
$2.49
+50.1% from low
Target vs 52W High
$16.14
-6.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%